skip to Main Content
TES Pharma | Drug Discovery Innovation


Following science to realise novel therapeutic opportunities


Orphan Nuclear Receptors and novel targets for new metabolic and oncology therapeutics


Combining experience with innovation across the drug discovery platform

TES Pharma is a research-based biopharmaceutical company, focussed on delivering first in class preclinical candidates for that unlock the potential of novel therapeutic targets and mechanisms. Our pipeline provides new approaches for metabolic diseases and oncology via small molecule therapeutics.

Back To Top